These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 18191554)

  • 1. Dissolution test for site-specific release isoniazid pellets in USP apparatus 3 (reciprocating cylinder): optimization using response surface methodology.
    Joshi A; Pund S; Nivsarkar M; Vasu K; Shishoo C
    Eur J Pharm Biopharm; 2008 Jun; 69(2):769-75. PubMed ID: 18191554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multivariate optimization of formulation and process variables influencing physico-mechanical characteristics of site-specific release isoniazid pellets.
    Pund S; Joshi A; Vasu K; Nivsarkar M; Shishoo C
    Int J Pharm; 2010 Mar; 388(1-2):64-72. PubMed ID: 20035851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statistical optimization of indomethacin pellets coated with pH-dependent methacrylic polymers for possible colonic drug delivery.
    Akhgari A; Afrasiabi Garekani H; Sadeghi F; Azimaie M
    Int J Pharm; 2005 Nov; 305(1-2):22-30. PubMed ID: 16236475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the formulation parameters on the characteristics of pellets.
    Fekete R; Zelkó R; Marton S; Rácz I
    Drug Dev Ind Pharm; 1998 Nov; 24(11):1073-6. PubMed ID: 9876562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
    Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of experimental design methodology in development and optimization of drug release method.
    Kincl M; Turk S; Vrecer F
    Int J Pharm; 2005 Mar; 291(1-2):39-49. PubMed ID: 15707730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osmotically regulated asymmetric capsular systems for simultaneous sustained delivery of anti-tubercular drugs.
    Prabakaran D; Singh P; Jaganathan KS; Vyas SP
    J Control Release; 2004 Mar; 95(2):239-48. PubMed ID: 14980772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statistical optimization of ranitidine HCl floating pulsatile delivery system for chronotherapy of nocturnal acid breakthrough.
    Roy P; Shahiwala A
    Eur J Pharm Sci; 2009 Jun; 37(3-4):363-9. PubMed ID: 19491027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of propranolol hydrochloride sustained-release pellets using box-behnken design and desirability function.
    Bodea A; Leucuta SE
    Drug Dev Ind Pharm; 1998 Feb; 24(2):145-55. PubMed ID: 15605444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of drug solubility on release behavior of calcium polysaccharide gel-coated pellets.
    Sriamornsak P; Kennedy RA
    Eur J Pharm Sci; 2007 Nov; 32(3):231-9. PubMed ID: 17889515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled drug release from Gelucire-based matrix pellets: experiment and theory.
    Siepmann F; Muschert S; Flament MP; Leterme P; Gayot A; Siepmann J
    Int J Pharm; 2006 Jul; 317(2):136-43. PubMed ID: 16621362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation and optimization of controlled release mucoadhesive tablets of atenolol using response surface methodology.
    Singh B; Chakkal SK; Ahuja N
    AAPS PharmSciTech; 2006 Jan; 7(1):E3. PubMed ID: 16584161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation of targeted isoniazid microspheres.
    Bosela AA; el-Sayed MM; Mahmoud MI
    Boll Chim Farm; 1998 Mar; 137(3):77-81. PubMed ID: 9611845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral matrix tablet formulations for concomitant controlled release of anti-tubercular drugs: design and in vitro evaluations.
    Hiremath PS; Saha RN
    Int J Pharm; 2008 Oct; 362(1-2):118-25. PubMed ID: 18640251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the USP dissolution test method A for enteric-coated articles by planar laser-induced fluorescence.
    Miller DA; Gamba M; Sauer D; Purvis TP; Clemens NT; Williams RO
    Int J Pharm; 2007 Feb; 330(1-2):61-72. PubMed ID: 17034967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and in vitro dissolution of isoniazid from ethylcellulose microcapsules.
    Barik BB; Ray S; Goswami N; Gupta BK; Ghosh LK
    Acta Pol Pharm; 2001; 58(1):65-8. PubMed ID: 11370290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation and statistical optimization of a novel crosslinked polymeric anti-tuberculosis drug delivery system.
    du Toit LC; Pillay V; Danckwerts MP; Penny C
    J Pharm Sci; 2008 Jun; 97(6):2176-207. PubMed ID: 17879985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leaky enteric coating on ranitidine hydrochloride beads: dissolution and prediction of plasma data.
    Bendas ER; Ayres JW
    Eur J Pharm Biopharm; 2008 Aug; 69(3):977-85. PubMed ID: 18424095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissolution testing of marketed rifampicin containing fixed dose combination formulations using a new discriminative media: a post marketing retrospective study.
    Panchagnula R; Kumar Bajpai A; Agrawal S; Ashokraj Y
    Pharmazie; 2006 Oct; 61(10):851-4. PubMed ID: 17069424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of dissolution profiles obtained from nifedipine extended release once a day products using different dissolution test apparatuses.
    Garbacz G; Golke B; Wedemeyer RS; Axell M; Söderlind E; Abrahamsson B; Weitschies W
    Eur J Pharm Sci; 2009 Sep; 38(2):147-55. PubMed ID: 19591927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.